It is known of other biomarkers for early detection of AKI, such as lipocalin associated with neutrophilic gelatinase (NGAL) and glomerular cystatin C, which can help reduce the delay in identifying the onset of the injury and contribute to renal recovery, but are still inaccessible in public services(6). This evidence concerns the gene MMP2 and acute kidney injury.